Evidence map›Paper›PMID 42694111›Full record

ArticleNPJ dementia2026

Regulators of interferon-responsive microglia uncovered by Genome-wide CRISPRi screening.

Amanda McQuade, Vincent Cele Castillo, Venus Hagan, Weiwei Liang, Thomas Ta, Reet Mishra, Olivia Teter, Layla Gomes, Bianca Gonzalez, Noam Teyssier and 2 more

Abstract read
In one paragraph

Article in NPJ dementia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Amanda McQuadeInstitute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA USA.
Vincent Cele CastilloInstitute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA USA.
Venus HaganInstitute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA USA.
Weiwei LiangInstitute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA USA.
Thomas TaInstitute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA USA.
Reet MishraInstitute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA USA.
Olivia TeterInstitute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA USA.
Layla GomesInstitute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA USA.
Bianca GonzalezInstitute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA USA.
Noam TeyssierInstitute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA USA.
Kun LengInstitute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA USA.
Martin KampmannInstitute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA USA.ORCID 0000-0002-3819-7019

Funding

Restorative practice in repairing harm and promoting safe and inclusive practices in the laboratory.T32GM136547 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Adrian Erlebacher, Anita Sil · 2020 to 2026
$4.5M
NIGMS NIH HHS T32 GM136547
6 · The paper itself

Abstract

Microglia dynamically support brain health through the induction of specialized activation states in response to injury or disease. Activation of the interferon-responsive microglia (IRM) state has been identified across neurodevelopmental windows, age-related cognitive decline, and neurodegenerative diseases. Functionally, IRM have been linked to synaptic pruning, dead cell removal, and neuroinflammation, making this state critical to brain homeostasis. While the functional importance of this state is becoming increasingly clear, our understanding of the regulatory networks that govern IRM induction remain incomplete. To systematically identify genetic regulators of the IRM state, we conducted a genome-wide CRISPR interference screen in human iPSC-derived microglia using IFIT1 as a representative IRM marker. We identified 772 genes that modulate IRM, including canonical type I interferon signaling genes (

Indexed as

Computational biology and bioinformaticsImmunologyNeurologyNeuroscience

Identifiers

PMID42694111
PMCPMC13538059

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.